Kshatakshina Chikitsa: Difference between revisions

Line 1,192:

===== Management of disease =====

**Experience based clinical practices:

*Experience based clinical practices:

***Applied principles in management of disease conditions

**Applied principles in management of disease conditions

***Styptic agents to stop bleeding

**Styptic agents to stop bleeding

***Binding agents for union of bones and injured tissues

**Binding agents for union of bones and injured tissues

***Nourishing regimen for depletion of body tissues

**Nourishing regimen for depletion of body tissues

***Rejuvenation therapies

**Rejuvenation therapies

====== ''Shodhana chikitsa'' (body purification treatments) and procedures ======

Purification treatments are not indicated in this disease.

Line 1,207:

Line 1,208:

====== ''Shamana chikitsa'' (pacification treatments) with list of formulations and medicines ======

{| class="wikitable"

|-

Line 1,246:

Line 1,248:

|}

Pathya or recommended diet: Light to digest food like shali rice, wheat, green gram, pomegranate, dry grapes, mango, amalaka, goat milk and ghee prepared of it, medicated milk, meat juice of goat

*''Pathya'' or recommended diet: Light to digest food like ''shali'' rice, wheat, green gram, pomegranate, dry grapes, mango, ''amalaka'', goat milk and ghee prepared of it, medicated milk, meat juice of goat

Pathya or recommended activity: Total bed rest

*''Pathya'' or recommended activity: Total bed rest

Apathya or contraindicated diet: Excess hot, pungent, salty food causing burning sensation, heavy to digest food.

*''Apathya'' or contraindicated diet: Excess hot, pungent, salty food causing burning sensation, heavy to digest food.

Apathya or contraindicated activity: Over exertion, strenuous exercise, weight lifting etc.

*''Apathya'' or contraindicated activity: Over exertion, strenuous exercise, weight lifting etc.

Parallel management of chest injury:

Use of sandhaniya drugs like laksha (mainly indicated for the healing of fracture of bone) and madhuyashti clearly indicates that in ~~kshata kshina~~ there is external trauma (ribs fracture leading to pneumothorax) that should be managed with quick remedies. As only conservative management for the ~~kshata- kshina~~ is described, it excludes the possibility of surgical interventions in ~~kshata-kshina~~ in that era. However nowadays the surgical procedures like tube drainage with or without medical pleurodesis, vacuum-assisted thoracostomy (VATS) with pleurodesis and/or closure of leaks and bullectomy, and open surgical procedures such as thoracotomy for pleurectomy or pleurodesis) are conducted to decrease the chances of incurability of ~~kshata ksheena~~. At the present time, it is necessary to elaborate the management of acute dreaded complications like pneumothorax and hematuria in separate chapter.

===== Parallel management of chest injury =====

Future Scope for Research:

• Exploring the clinical evidences for the immunomodulator and hemostatic properties of Sida Veronicaefolia Lam. (Nagabala).

Use of ''sandhaniya'' drugs like ''laksha'' (mainly indicated for the healing of fracture of bone) and ''madhuyashti'' clearly indicates that in ''kshatakshina'' there is external trauma (ribs fracture leading to pneumothorax) that should be managed with quick remedies. As only conservative management for the ''kshatakshina'' is described, it excludes the possibility of surgical interventions in ''kshatakshina'' in that era. However nowadays the surgical procedures like tube drainage with or without medical pleurodesis, vacuum-assisted thoracostomy (VATS) with pleurodesis and/or closure of leaks and bullectomy, and open surgical procedures such as thoracotomy for pleurectomy or pleurodesis) are conducted to decrease the chances of incurability of ''kshatakshina''. At the present time, it is necessary to elaborate the management of acute dreaded complications like pneumothorax and hematuria in separate chapter.

• In vitro and in-vivo evaluation of hemostatic property of Boerhavia diffusa and clinical demonstration of its use in hemoptysis.

• Exploring the role of ~~autoantibodies~~ in the pathogenesis of tuberculosis and its relation with genetic suspectibility.

==== Future Scope for Research ====

• Evaluating the role of laksha (Laccifer lacca) and madhuyasti (Glycyrrhiza glabra) in rehabilitating pulmonary tissues in acute pulmonary injury.

*Exploring the clinical evidences for the immunomodulator and hemostatic properties of Sida Veronicaefolia Lam. (''Nagabala'').

*In-vitro and in-vivo evaluation of hemostatic property of Boerhavia diffusa and clinical demonstration of its use in hemoptysis.

*Exploring the role of auto-antibodies in the pathogenesis of tuberculosis and its relation with genetic suspectibility.

*Evaluating the role of ''laksha'' (Laccifer lacca) and ''madhuyasti'' (Glycyrrhiza glabra) in rehabilitating pulmonary tissues in acute pulmonary injury.

• Evaluating role of anti-oxidant drugs [like amalaki (Emblica officinalis)] and vitamin C in the management of chronic inflammatory as well as infectious pulmonary diseases.

@@ Line 1,192: / Line 1,192: @@
 ===== Management of disease =====
-**Experience based clinical practices:
+*Experience based clinical practices:
-***Applied principles in management of disease conditions
+**Applied principles in management of disease conditions
-***Styptic agents to stop bleeding
+**Styptic agents to stop bleeding
-***Binding agents for union of bones and injured tissues
+**Binding agents for union of bones and injured tissues
-***Nourishing regimen for depletion of body tissues
+**Nourishing regimen for depletion of body tissues
-***Rejuvenation therapies
+**Rejuvenation therapies
 ====== ''Shodhana chikitsa'' (body purification treatments) and procedures ======
 Purification treatments are not indicated in this disease.
@@ Line 1,207: / Line 1,208: @@
 ====== ''Shamana chikitsa'' (pacification treatments) with list of formulations and medicines ======
 {| class="wikitable"
 |-
@@ Line 1,246: / Line 1,248: @@
 |}
-Pathya or recommended diet:  Light to digest food like shali rice, wheat, green gram, pomegranate, dry grapes, mango, amalaka, goat milk and ghee prepared of it, medicated milk, meat juice of goat
+*''Pathya'' or recommended diet:  Light to digest food like ''shali'' rice, wheat, green gram, pomegranate, dry grapes, mango, ''amalaka'', goat milk and ghee prepared of it, medicated milk, meat juice of goat
-Pathya or recommended activity: Total bed rest
+*''Pathya'' or recommended activity: Total bed rest
-Apathya or contraindicated diet: Excess hot, pungent, salty food causing burning sensation, heavy to digest food.
+*''Apathya'' or contraindicated diet: Excess hot, pungent, salty food causing burning sensation, heavy to digest food.
- Apathya or contraindicated activity: Over exertion, strenuous exercise, weight lifting etc.
+*''Apathya'' or contraindicated activity: Over exertion, strenuous exercise, weight lifting etc.
-Parallel management of chest injury:
-Use of sandhaniya drugs like laksha (mainly indicated for the healing of fracture of bone) and madhuyashti clearly indicates that in kshata kshina there is external trauma (ribs fracture leading to pneumothorax) that should be managed with quick remedies. As only conservative management for the kshata- kshina is described, it excludes the possibility of surgical interventions in kshata-kshina in that era. However nowadays the surgical procedures like tube drainage with or without medical pleurodesis, vacuum-assisted thoracostomy (VATS) with pleurodesis and/or closure of leaks and bullectomy, and open surgical procedures such as thoracotomy for pleurectomy or pleurodesis) are conducted to decrease the chances of incurability of kshata ksheena. At the present time, it is necessary to elaborate the management of acute dreaded complications like pneumothorax and hematuria in separate chapter.
+===== Parallel management of chest injury =====
-Future Scope for Research:
-•	Exploring the clinical evidences for the immunomodulator and hemostatic properties of Sida Veronicaefolia Lam. (Nagabala).
+Use of ''sandhaniya'' drugs like ''laksha'' (mainly indicated for the healing of fracture of bone) and ''madhuyashti'' clearly indicates that in ''kshatakshina'' there is external trauma (ribs fracture leading to pneumothorax) that should be managed with quick remedies. As only conservative management for the ''kshatakshina'' is described, it excludes the possibility of surgical interventions in ''kshatakshina'' in that era. However nowadays the surgical procedures like tube drainage with or without medical pleurodesis, vacuum-assisted thoracostomy (VATS) with pleurodesis and/or closure of leaks and bullectomy, and open surgical procedures such as thoracotomy for pleurectomy or pleurodesis) are conducted to decrease the chances of incurability of ''kshatakshina''. At the present time, it is necessary to elaborate the management of acute dreaded complications like pneumothorax and hematuria in separate chapter.
-•	In vitro and in-vivo evaluation of hemostatic property of Boerhavia diffusa and clinical demonstration of its use in hemoptysis.
-•	Exploring the role of autoantibodies in the pathogenesis of tuberculosis and its relation with genetic suspectibility.
+==== Future Scope for Research ====
-•	Evaluating the role of laksha (Laccifer lacca) and madhuyasti (Glycyrrhiza glabra) in rehabilitating pulmonary tissues in acute pulmonary injury.
+*Exploring the clinical evidences for the immunomodulator and hemostatic properties of Sida Veronicaefolia Lam. (''Nagabala'').
+*In-vitro and in-vivo evaluation of hemostatic property of Boerhavia diffusa and clinical demonstration of its use in hemoptysis.
+*Exploring the role of auto-antibodies in the pathogenesis of tuberculosis and its relation with genetic suspectibility.
+*Evaluating the role of ''laksha'' (Laccifer lacca) and ''madhuyasti'' (Glycyrrhiza glabra) in rehabilitating pulmonary tissues in acute pulmonary injury.
 •	Evaluating role of anti-oxidant drugs [like amalaki (Emblica officinalis)] and vitamin C in the management of chronic inflammatory as well as infectious pulmonary diseases.
 Further reading: